• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    Mixed neuroendocrine-non-neuroendocrine neoplasms of the digestive system: A mini-review

    2022-06-11 07:23:08DeepakToorJonathanLoreeZuHuaGaoGangWangChenZhou
    World Journal of Gastroenterology 2022年19期

    Deepak Toor, Jonathan M Loree, Zu-Hua Gao, Gang Wang, Chen Zhou

    Abstract Mixed neuroendocrine-non-neuroendocrine neoplasms (MiNENs) are rare mixed tumors containing both neuroendocrine (NE) and non-NE components. Each component must occupy at least 30 % of the tumor volume by definition. Recent molecular evidence suggests MiNENs are clonal neoplasms and potentially harbor targetable mutations similar to conventional carcinomas. There have been multiple changes in the nomenclature and classification of MiNENs which has created some confusion among pathologists on how to integrate the contributions of each component in a MiNEN, an issue which in turn has resulted in confusion in communication with front-line treating oncologists. This mini review summarizes our current understanding of MiNENs and outline diagnosis,prognosis, and management of these neoplasms. The authors emphasize the importance of treating the most aggressive component of the tumor regardless of its percentage volume.

    Key Words: Mixed neuroendocrine non-neuroendocrine neoplasms; Mixed adenoneuorendocrine carcinoma; Mixed neuroendocrine neoplasms; Neuroendocrine;Non-neuroendocrine

    INTRODUCTION

    Mixed neuroendocrine-non-neuroendocrine neoplasms (MiNENs) are tumors containing two or more histologically distinct components with one component showing neuroendocrine (NE) differentiation[1 ]. The non-NE component consists of an adenocarcinoma in over 90 % of cases, but it can consist of any other epithelial neoplasm, including squamous cell carcinoma or hepatocellular carcinoma[1 ,2 ]. By definition each component must individually comprise > 30 % of the total tumor volume in order for the tumor to qualify as a MiNEN[3 ].

    MiNENs are a specific subtype of mixed NE neoplasms (Figure 1 )[4 ]. Traditionally, mixed NE neoplasms include composite tumor, collision tumors, amphicrine tumors and non-NE neoplasms with focal neuroendocrine differentiation (NNE-NEDs). Strictly speaking, in MiNENs the distinct NE and non-NE components are intimately intermingled and both are derived from a common single precursor cell, morphologically expressing usually as composite tumors. Collision tumors consist of two independent primary neoplasms which have grown into the same space by chance. Each neoplasm is derived from a separate precursor cell which has independently undergone its own molecular evolution[5 ]. Amphicrine neoplasms consist of a single cell type in which each cell displays both NE and non-NE phenotypes simultaneously. For example, electron microscopy may demonstrate both mucous vacuoles and neurosecretory granules in the same cell. These tumors are extremely rare, with approximately only 4 reported in the stomach[6 ] but are slightly more common in the pancreas. Despite that collision tumors might not come from a common single precursor cell; they have still been referred to as MiNENs by authors based on the traditional practice.

    NNE-NEDs are non-NE neoplasms which show NE differentiation but not enough to meet the criteria to be considered MiNENs. The exact percentage threshold of NED required to be considered a MiNEN is artificial and will likely continue to evolve in the future as we learn more about these neoplasms. The current 30 % threshold was originally defined arbitrarily in 1987 to recognize and create a new diagnostic entity for truly mixed NE tumors with substantial amounts of both non-NE and NE components, and to exclude non-NE tumors with scattered NE cells of uncertain clinical significance[4 ,7 ]. Although it has served a valuable role in the establishment of MiNENs as distinct diagnostic entities,this cut-off does not have a basis in clinical or scientific evidence[1 ]. Recent studies suggest a lower threshold may be more appropriate, with even 10 % NED significantly affecting prognosis, thus raising the possibility the formally defined threshold may change in the future[8 ,9 ]. Indeed, poorly differentiated NE or even non-NE components, even when < 5 % of the tumor volume, may determine patient outcome. Regardless of what the threshold is, it is important to note neoplasms may show a spectrum of divergent NED, and that only a subset of these neoplasms should be classified as MiNENs.

    Other entities which may be confused with MiNENs include usual adenocarcinomas displaying aberrant expression of NE markers (i.e.,synaptophysin and chromogranin) but no histologically recognizable NE morphology[7 ]. These features do not qualify a neoplasm as a MiNEN, and aberrant synaptophysin expression in conventional adenocarcinomas does not affect prognosis[10 ]. Neoplasms which overgrow and entrap physiologic NE structures, for example acinar adenocarcinoma in the pancreas which can entrap normal physiologic islets of Langerhans, should also not be mistaken for MiNENs despite the pitfall of positive staining for NE markers[7 ].

    NOMENCLATURE

    Figure 1 Classification of mixed neuroendocrine neoplasms. Mixed neuroendocrine-non-neuroendocrine neoplasms are specific mixed neuroendocrine tumors, which show an intimate mixture of neuroendocrine and non-neuroendocrine cells and are both derived from a common precursor cell. MiNEN: Mixed neuroendocrine-non-neuroendocrine neoplasms.

    The individual components of MiNENs are common entities which pathologists and oncologists encounter routinely. The major challenge in understanding MiNENs is simply an issue of nomenclature.Unfortunately, the nomenclature has undergone numerous rapid and successive changes over the past 20 years. This has been complicated by substantial changes in the nomenclature for simple pure NE neoplasms themselves which have occurred over the same timeframe. The potential clinical confusion which may occur because of these rapid changes is not insignificant. An illustrative example of such potential confusion comes from appendiceal goblet cell neoplasms which have similarly undergone numerous changes in nomenclature. Two cases diagnosed as "goblet cell adenocarcinoma" and"adenocarcinoma ex goblet cell carcinoid" were misinterpreted by oncologists as NE tumors and then considered for inappropriate adjuvant chemotherapy[11 ].

    A conceptual framework for understanding MiNENs is shown in Figure 2 . In order to constitute a MiNEN a tumor must show at least two lines of differentiation, one of which is NE and the other of which is epithelial but non-NE. In the digestive system only, there is an additional stipulation that each component of the neoplasm is required to be malignant in order for it to qualify as a MiNEN[3 ]. Lowgrade NE tumors, formerly known as carcinoids, satisfy this "malignant" requirement because of their potential for metastasis, despite their usually indolent behavior[1 ,3 ]. However indolent non-NE epithelial tumors, such as adenomas or papillomas, do not metastasize and so would not constitute MiNENs in the digestive system[3 ]. For example, mixed adenomas well-differentiated NE tumors, or"MANETs", consisting of a composite tubular adenoma-carcinoid tumor, are no longer considered MiNENs with these updated criteria[12 ]. Similarly, in-situ lesions such as intraductal papillary mucinous neoplasms of the pancreas were formerly included as potential non-NE components of digestive system MiNENs, but now have been excluded by the latest WHO classification[1 ,3 ]. The non-NE component is required to be an invasive carcinoma.

    Although perhaps daunting, becoming familiar with the host of names that has been used to refer to MiNENs in the past may help reduce confusion in clinical practice. We will attempt to briefly summarize the history of the nomenclature of MiNENs towards this end. We begin by describing the changes in nomenclature of pure NE neoplasms, before moving on to the broader category of MiNENs.

    NE neoplasms

    The nomenclature of NE neoplasms in the digestive system has undergone a series of changes in the last 20 years. After being first recognized in 1907 , NE neoplasms were designated "carcinoid tumors" and referred to as such for almost a century thereafter[8 ,13 ]. By 1994 poorly differentiated NE neoplasms were noted to have a drastically worse prognosis than their well-differentiated counterparts[8 ,14 ]. The poorly differentiated neoplasms were designated “small cell carcinomas”. The term carcinoid continued to refer to well-differentiated NE neoplasms.

    Figure 2 Conceptual framework for mixed neuroendocrine-non-neuroendocrine neoplasm of the digestive system. The tumor must include one neuroendocrine component and one non-neuroendocrine component. In the digestive system both components must have metastatic potential, excluding benign non-neuroendocrine neoplasms such as adenomas or squamous papillomas. NET: Neuroendocrine tumors; NEC: Neuroendocrine carcinomas.

    Increasing use of Ki-67 immunohistochemistry revealed a wide spectrum of proliferative rates within carcinoid tumors and small cell carcinomas. A grading system based on Ki-67 index was proposed in 2006 and formally adopted by the WHO classification in 2010 [15 ,16 ]. NE tumors with low Ki-67 indices(≤ 20 %; grades 1 or 2 ) were called neuroendocrine tumors (NETs) while tumors with high Ki-67 index (>20 %; grade 3 ) were called neuroendocrine carcinomas (NECs).

    Grade 3 tumors were recently recognized to consist of two types of tumors, although both have increased Ki-67 indices. One type of tumors shows well-differentiated morphology while another type shows poorly differentiated morphology[8 ]. Further studies have revealed tumors showing poorly differentiated morphology have half the survival of their well-differentiated counterparts[8 ]. Genetic studies further show the two tumor populations actually developviaentirely separate and independent molecular pathways[8 ,17 ]. These findings have led to any poorly differentiated tumor being referred to as a NEC, regardless of Ki-67 index. Well-differentiated tumors which are designated NETs and further graded according to their proliferation rate[3 ].

    Any NE neoplasm, either a NET or a NEC, can constitute the NE component of a MiNEN.

    Non-NE component

    Mixed NE neoplasms were first recognized in 1924 , only shortly after pure NE neoplasms themselves were first recognized[7 ,18 ]. In 1987 Lewin[4 ] formally proposed a classification system for mixed NE neoplasms in which he termed what we now call MiNENs as “composite glandular-endocrine cell carcinomas”[4 ]. His classification system distinguished these tumors from collision tumors and amphicrine tumors, as well as from usual adenocarcinomas with < 30 % NED.

    In 2000 these neoplasms were adopted into theWHO Classification of Tumors of the Digestive Systemas“mixed exocrine-endocrine carcinomas” (MEECs)[7 ,19 ]. This terminology was short-lived and changed to “mixed adenoneuroendocrine carcinoma” (MANEC) in the subsequent 2010 edition of the classification[16 ].

    It soon became apparent adenocarcinomas were not the only non-NE neoplasms observed in mixed NE tumors. Other epithelial neoplasms, such as squamous cell carcinomas and hepatocellular carcinomas, were also observed in mixed NE neoplasms[1 ,7 ]. This prompted “mixed adenoneuroendocrine carcinomas” (MANECs) to instead be viewed as “mixed neuroendocrine-non-neuroendocrine carcinomas” (Figure 3 ).

    MiNENs

    In 2016 , La Rosa et al[1 ] proposed the term "mixed neuroendocrine-non-neuroendocrine neoplasms"(MiNENs)[1 ]. The intention was to create an umbrella term for mixed NE neoplasms broad enough to encompass all the changes we have discussed so far, while also being generalizable to any mixed NE tumor occurring in any organ in the body. The latter task is difficult considering the heterogeneity in nomenclature for NE neoplasms in different sites such as the lung. It is even more difficult if one anticipates the nomenclature for pure NE neoplasms continuing to evolve in other organs such as it has in the digestive system.

    MiNENs are 'neoplasms' instead of 'carcinomas' because benign non-NE components such as adenomas or papillomas can still be a part of MiNENs in sites outside of the digestive system[1 ]. This had been the case in the digestive system as well until only recently when the latest WHO classification was published in 2019 .

    Figure 3 Evolution of the terminology of mixed neuroendocrine-non-neuroendocrine neoplasm. The terminology has been broadened to include other non-neuroendocrine epithelial components beyond adenocarcinoma as well as including indolent or benign tumors such as neuroendocrine tumors. NE:Neuroendocrine; NEC: Neuroendocrine carcinoma; NET: Neuroendocrine tumor; MEEC: Mixed exocrine-endocrine carcinoma; MANEC: Mixed adenoneuroendocrine carcinoma; MiNEN: Mixed neuroendocrine-non-neuroendocrine neoplasm.

    The current prevailing view is that MiNENs are clonal neoplasms derived from a single pluripotent stem cell[8 ]. Multiple studies have compared the mutational landscape in the NE and non-NE components and have demonstrated a common trunk of mutations shared between them, beyond which are further mutations specific to each component[20 -22 ]. Interestingly these shared mutations are very similar to the mutations found in standard pure adenocarcinomas from the same anatomic site[22 ]. For example, in the colon, MiNENs can showBRAF,KRAS, andAPCmutations in both components[22 ].The mutated genes are expressed at similar levels in both components, and expression is significantly altered in comparison to normal background tissue[20 ,21 ].

    Some authors have theorized MiNENs may begin as non-NE tumors and then at some point transdifferentiate to form an aggressive NEC component[2 ,23 -26 ]. Several reports suggestc-MycandSMARCAmutations may play a role in trans-differentiation, with one study even finding only a single additionalSMARCAmutation in the NE component of a MiNEN[23 -25 ]. Other studies have shown increased chromosomal aberrations and allelic imbalances in the NE component[26 ].

    CHALLENGES IN DIAGNOSIS

    Definitive diagnosis of a MiNEN usually follows after surgical resection. The presurgical biopsy diagnoses are roughly evenly split between 1 /3 adenocarcinoma, 1 /3 NEC, and 1 /3 suspicious for MiNEN[2 ]. The NE component tends to lie deeper in the tumor which can influence the diagnosis on biopsy depending on the depth of tumor sampled[27 ,28 ].

    Identifying the components

    Diagnosing a MiNEN is equivalent to individually diagnosing the constituent components with a few additional steps. Neither the NE nor non-NE components differ from their pure counterparts, including their immunohistochemical profiles.

    Figure 4 illustrates a typical MiNEN of colon origin. Both morphologic and immunohistochemical evidence of NED is required to diagnose a NE component in a MiNEN[3 ,7 ]. Morphologic evidence is required avoid the pitfall of focal aberrant NE marker expression on immunohistochemistry in otherwise standard non-NE tumors, a commonly recognized phenomenon with no current known clinical significance[10 ,29 ]. Common markers of NED that are used include synaptophysin, chromogranin, INSM1 , CD56 , and neuron-specific enolase. Synaptophysin is traditionally be regarded as the most sensitive and chromogranin as the most specific[30 ].

    The NE component may be either a NEC or a NET[3 ,7 ]. Ki-67 proliferative index (or equivalently mitotic rate) should be reported for all NE neoplasms, including the NE component present in MiNENs.NETs are graded as usual by Ki-67 index: Grade 1 tumors are < 3 %; grade 2 between 3 %-20 %; and grade 3 > 20 %[3 ]. Grade 3 NETs usually have a Ki-67 index less than 60 %, while the indices for NECs are higher, typically more than 50 %-60 %[8 ].

    Figure 4 Histopathology of a mixed neuroendocrine-non-neuroendocrine neoplasm of colon. A: Hematoxylin and eosin (H&E) stain of mixed neuroendocrine-non-neuroendocrine neoplasm. On the right side is a well-differentiated invasive adenocarcinoma. On the left side is a poorly differentiated neuroendocrine carcinoma (20 ×, H&E); B: The adenocarcinoma component is positive for cytokeratin 20 , but the neuroendocrine component is negative (20 ×); C:Positive synaptophysin staining in the neuroendocrine component but negative staining in the adenocarcinoma component (20 ×); D: Positive CDX2 staining in both adenocarcinoma and neuroendocrine carcinoma components (20 ×); E: Merging area of adenocarcinoma and neuroendocrine carcinoma components (20 ×); F:Positive synaptophysin staining of neuroendocrine cells in the merged area (20 ×).

    The majority of MiNENs do not contain NETs but rather contain poorly differentiated NECs. Tumor cells in NECs show nuclear crowding and pleomorphism. Nuclei are hyperchromatic with increased nuclear membrane irregularity. Single cells are common, and mitoses are obvious. Necrosis can be present, and nuclei display smearing or crush artifact. NE markers remain sensitive, however immunohistochemical markers for the primary site of origin are lost[8 ,30 ]. Aberrant expression of TTF-1 and CDX-2 is common, making these markers unreliable and a potential pitfall for mistaking the site of origin[8 ]. The average Ki-67 proliferative index of NECs in MiNENs is 70 %[30 ].

    Morphologically NECs can show either small or large cell patterns. Small cell morphology is similar to traditional small cell carcinoma elsewhere with small uniform round to oval nuclei and evenly distributed finely granular (“salt and pepper”) chromatin. Cytoplasm is scant. Cells are crowded with nuclear moulding and indistinct cell membranes. In contrast, large cell NECs (LCNECs) have a larger cell size than small cell carcinoma and a vesicular nucleus with prominent nucleolus. They can have appreciable eosinophilic cytoplasm. Distinguishing LCNECs from small cell carcinoma can sometimes be a difficult task. Ki-67 index can potentially be helpful as the index of LCNECs ranges from 40 %-80 %while small cell carcinoma averages 80 %[31 ]. In MiNENs the NEC component is more commonly a LCNECs than a small cell carcinoma[32 ,33 ].

    The non-NE component of MiNENs is adenocarcinoma 92 % of the time[2 ]. Squamous cell carcinoma,hepatocellular carcinoma, and mixed adenosquamous carcinoma make up the majority of remaining non-NE components in reported cases thus far[2 ].

    Extent of NE differentiation

    The exact threshold of NED required to define a tumor as a MiNENvsan NNE-NED is an area of current controversy in the literature. As mentioned, the 30 % threshold which persists today was originally chosen arbitrarily. A commonly cited and relatively recent study by Parket al[9 ] provides evidence arguing in favor of lowering the threshold to 10 %[9 ]. The authors examined 88 gastric carcinomas with varying degrees of NED and compared overall survival to 650 gastric carcinomas with no NED. NED of just under 10 % was associated with worse survival: Overall 5 -year survival in cases with < 10 % NED was 85 .6 % compared to only 53 .3 % survival in cases with ≥ 10 % NED.

    Another similar study found 20 % NED to be associated with significantly worse prognosis in adenocarcinomas, again suggesting the 30 % threshold may be too high[34 ]. The current formal threshold for diagnosing a MiNEN remains 30 % but this is likely to be lowered in the future. In the interim while this does preclude a diagnosis of MiNEN in cases with 10 %-30 % NED, we recommend always quantifying the percentage of NED in non-NE tumors and informing the oncologist of the possible prognostic impact, for example by making a diagnostic comment citing the studies above.Regardless of how the report is handled, the possible prognostic impact of 10 %–30 % is an important topic to be raised in multidisciplinary meetings discussing diagnosis and management of these rare tumors.

    The significance of divergent differentiation in NECs is a less well explored topic. This may be because even small degrees of NED, beginning at as little as 10 % as mentioned above, quickly approach the same dismal prognosis as NECs regardless of the size of the non-NE component (Table 1 ).

    Grading

    There is currently no widely accepted system for grading MiNENs. This is somewhat unfortunate because MiNEN is an umbrella term for a wide range of neoplasms whose behaviour can range from indolent (i.e., a MiNEN in which a NET is the most biologically aggressive component) to aggressively malignant, paralleling the prognosis of NECs. Simply designating a tumor as a MiNEN is insufficient and does not convey much useful information. Therefore, it is incumbent upon the pathologist to clearly communicate the nature and aggressiveness of each component present in the tumor to ensure appropriate management.

    Once upon a time...One summer s day a little tailor sat on his table by the window in the best of spirits, and sewed for dear life. As he was sitting thus a peasant woman came down the street, calling out: Good jam to sell, good jam to sell. This sounded sweetly in the tailor s ears; he put his frail1 little head out of the window, and shouted: up here, my good woman, and you ll find a willing customer. The woman climbed up the three flights of stairs with her heavy basket to the tailor s room, and he made her spread out all the pots in a row before him.

    The original publication by La Rosaet al[1 ] in which the term MiNEN was coined also proposed a grading scheme in which MiNENs were divided into low-grade, intermediate grade, and high grade categories[1 ]. Tumors with a NEC component, which constitute the vast majority of MiNENs, would be designated high grade neoplasms. Tumors in which the non-NE component was the most aggressive,such as adenocarcinomas with a NET component, would be intermediate grade. Indolent tumors in which a NET was the most aggressive component would be low-grade. This scheme succinctly classifies MiNENs according to their most aggressive component. It is also clinically useful because the most aggressive component usually drives prognosis and management. While the scheme may not be widely used, it still serves as a useful guide as to how to portray grade in MiNENs.

    Staging

    The fact that MiNENs are considered single clonal neoplasms greatly simplifies staging. The two components do not need to be staged separately as they would in a collision tumor. Standard TNM staging applies asperAJCC guidelines, using the same protocols as for other carcinomas from the same body site. For the rare MiNENs in which a NET is the most aggressive component the protocol for NETs from the same body site is used. There does not appear to be literature yet to consider alternative methods for staging MiNENs.

    Lymph nodes

    While lymph node staging proceeds asperstaging of the rest of the MiNEN as described above, the composition of lymph node metastases in MiNENs is an interesting issue because of the many different possible scenarios: Only one component may have metastasized, or both may have; the components may metastasize together to the same lymph node, or separately to different lymph nodes. Further it is interesting to consider whether the metastatic component of a MiNEN is a better marker of the biologic behavior of the tumor than the de facto assumption that behaviour is dictated by the worst component found in the primary tumor.

    The pattern of metastasis in MiNENs was investigated in a study of 80 patients[35 ]. In approximately 70 % of patients only one component metastasized; this was usually the more aggressive NEC component. In 20 % of patients both components metastasized, but none were found together in the same lymph node. In 10 % of patients there was lymph node metastasis present containing both components within the same node.

    In terms of the components present in metastases, they reflected the composition of the primary tumor; in a tumor composed of 60 % NEC and 40 % adenocarcinoma, roughly 60 % of metastases would be NEC and 40 % would be adenocarcinoma[35 ].

    Included in the study were 3 cases of NNE-NEDs. In all 3 of these cases the metastases were composed solely of the NEC component. Notably, by current criteria these tumors would not have qualified as MiNENs, providing further evidence that < 30 % NED can be biologically significant.

    The question of whether the biologic behaviour of MiNENs is better reflected by the metastatic component or the most aggressive component in the primary tumor is moot since these data show the composition of the metastases simply reflect the composition of the primary tumor; in other words, it is unlikely further useful information will be gained by determining the pattern of lymph node metastasis once the composition of the primary tumor is known. The grading scheme proposed by La Rosa appears to be the most useful gauge of the potential biological behavior of the tumor.

    Reporting

    'MiNEN' is not a diagnosis but rather an umbrella term for mixed NE neoplasms[1 ]. The term in and of itself does not convey useful information to the oncologist. The useful information is knowing the components which make up the tumor, and pathologists must ensure these are communicated clearly toallow oncologists to stratify risk and plan management accordingly.

    Table 1 Prognostic impact of neuroendocrine differentiation (summarized from Park et al[9 ])

    Figure 5 shows the example of the pathology report of a MiNEN. The first line of the report should identify that the tumor is a MiNEN. Because there is currently no widely accepted grading system,grade must be conveyed within the next few lines. The most aggressive or high-grade component should be listed first, and the system by La Rosaet al[1 ] serves a useful guide here[1 ]. A NEC component is the highest possible grade neoplasm found in MiNENs and should always be listed first.Next in the hierarchy of grade usually comes a non-NE carcinoma component, usually an adenocarcinoma, which is then followed by a NET component, and then lastly followed by the lowest grade component possible, a benign epithelial neoplasm such as an adenoma or papilloma. Accordingly, La Rosa's scheme describes tumors driven by a NEC component as high-grade, tumors driven by a carcinoma component intermediate grade, and tumors driven by a NET component low-grade or indolent. For each component listed the histologic subtype and grade should be described the same way they would be as if the component were a pure neoplasm. The percentage of total tumor volume occupied by each component should also be listed.

    We recommend designating non-NE tumors with 10 %-30 % NED (NNE-NEDs) as 'mixed neoplasms'and then reporting them in the same manner as a MiNEN. A diagnostic comment citing the Parket al[9 ]and Jianget al[34 ] studies mentioning the possible prognostic impact of NE components occupying <30 % of the tumor volume may help provide important background information for these rare tumors[9 ,34 ].

    Because of their genetic similarity to adenocarcinomas, we recommend performing the same molecular studies on MiNENs as one would perform for an adenocarcinoma from the same anatomic site. Alterations involving MMR, BRAF V600 E, and Her-2 have been demonstrated to exist in both components of MiNENs, inviting the exciting possibility of using the same targeted therapies during treatment[22 ,25 ,36 ]. Although ideally both components in a MiNEN would be tested individually to allow for better prediction of how the entire tumor will respond to a targeted therapy, in practice this may be very difficult or impossible to achieve with the closely intermingled components.

    PROGNOSIS AND MANAGEMENT

    The rarity of MiNENs, combined with their changing terminology over the years, has made it difficult to examine outcomes data. Controversy exists as to whether MiNENs behave better than pure NECs,but ultimately the prognosis appears to be similar[2 ,30 ,37 ,38 ]. A recently reported survival comparison of 503 NECs, 401 MiNENs, and 2785 adenocarcinomas of the stomach showed that the 5 -year diseasefree survival (DFS) was 47 .5 %, 51 .1 %, and 57 .8 % respectively[37 ]. The shorter DFS of NECs and MiNENs compared to adenocarcinoma was statistically significant while the difference between NECs and MiNENs was not.

    In the digestive system in general, 82 % of MiNENs present with localized disease and 18 % present with distant metastases[2 ]. Patients with localized disease generally proceed to surgical resection. Select patients with advanced disease may undergo palliative resection[38 ]. The median overall survival for localized MiNENs, including regional lymph node metastases (Stages I-III), is 39 mo. For advanced disease with distant metastasis (Stage IV) median overall survival is 11 mo[38 ].

    MiNENs may be missed in patients with an accessible metastasis that is used for the initial diagnostic biopsy. These cases may be diagnosed as pure NECs or pure adenocarcinomas, if resection is not indicated and further tissue is not sampled, thus may result in under recognition of MiNENs[30 ]. This leads to bias in outcome data as lower stage tumors are more likely to undergo surgical resection and be diagnosed as MiNENs whereas higher stage tumors are more likely to be missed and labeled pure NECs or pure adenocarcinomas. Thus, MiNENs may appear to have improved prognosis, when in reality they are just more likely to be diagnosed at a lower stage.

    Figure 5 Sample pathology report. MiNEN: Mixed neuroendocrine-non-neuroendocrine neoplasm.

    Management for these rare tumors is usually discussed at multidisciplinary rounds with the expertise of pathologists and oncologists who have special interest in NE neoplasms. Treatment is tailored towards the most aggressive component of the tumor, which is usually a NEC. MiNENs in which the most aggressive component is an adenocarcinoma (i.e., tumors composed of adenocarcinomas with a NET component) are much rarer, but in these cases treatment is tailored towards the adenocarcinoma component.

    No guidelines exist currently for adjuvant or neoadjuvant chemotherapy. NEC driven tumors are usually treated with etoposide and cisplatin-based regimens[2 ,27 ,39 ]. Adenocarcinoma driven cancers are commonly treated with 5 -FU based backbones, however treatment options vary based on the site of the primary, with chemotherapies for MiNENs arising from a particular organ mirroring the systemic therapy for adenocarcinomas at that site. The oncologist may attempt a tailored combination of therapy in which the agents employed display efficacy against both components[30 ]. Radiation therapy has been suggested in tumors from the esophagus, stomach, rectum, and anus[40 ].

    The genetic similarity of MiNENs to adenocarcinomas and reports ofKRAS, BRAF V600E, APC,MMR, andHER-2amplifications occurring in both components of MiNENs invites the possibility of targeted therapies in these tumors[2 ,22 ,40 ,41 ]. One series of 44 cases found MMR deficiency in 39 % of these tumors[40 ]. While this did not appear to have prognostic impact, it is an exciting finding raising the possibility for potential response to programmed death 1 blockade.

    CONCLUSION

    Mixed NE neoplasms have a complex history particularly in regard to nomenclature which has evolved alongside our increasing recognition of these tumors. The term 'MiNEN' was created to encompass a broader range of non-NE epithelial components beyond just adenocarcinomas. The term also incorporates updates in terminology used for NE neoplasms. MiNEN can be used to refer to tumors outside of the digestive system as well, although the digestive system has been the leading-edge area for these tumors. Diagnosis is in fact very familiar to both pathologists and oncologists alike, with no significant differences compared to diagnosis of each individual neoplasms. Staging is simplified because MiNENs are considered single clonal neoplasms. Prognosis and management are based on, and in general equivalent to, that of the most aggressive component.

    FOOTNOTES

    Author contributions:Toor D performed the majority of the writing; Wang G provided input in writing the paper and contributed histology images; Loree JM provided input and opinions on the clinical management portion of the writing; Gao ZH defined the concepts and ensured the overall quality of the writing; Zhou C designed the outline and coordinated the writing of the paper.

    Conflict-of-interest statement:JL has received consulting fees from Taiho, Ipsen, Novartis, Amgen, Eisai, and Bayer;research funding from Ipsen Biopharmaceuticals, Amgen, and Foundation Medicine.

    Open-Access:This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BYNC 4 .0 ) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is noncommercial. See: https://creativecommons.org/Licenses/by-nc/4 .0 /

    Country/Territory of origin:Canada

    ORCID number:Deepak Toor 0000 -0002 -1859 -1246 ; Jonathan M Loree 0000 -0001 -8189 -2132 ; Zu-Hua Gao 0000 -0001 -7232 -0933 ; Gang Wang 0000 -0002 -0225 -4173 ; Chen Zhou 0000 -0002 -7898 -4201 .

    S-Editor:Fan JR

    L-Editor:A

    P-Editor:Fan JR

    久久午夜亚洲精品久久| 丰满的人妻完整版| 18禁观看日本| 又紧又爽又黄一区二区| 超碰成人久久| 757午夜福利合集在线观看| 看黄色毛片网站| 亚洲av电影不卡..在线观看| 亚洲黑人精品在线| 搡老妇女老女人老熟妇| 九色成人免费人妻av| 国产一区二区激情短视频| 99久久精品热视频| 久久精品夜夜夜夜夜久久蜜豆 | 亚洲精品中文字幕在线视频| 激情在线观看视频在线高清| 曰老女人黄片| 激情在线观看视频在线高清| 老熟妇乱子伦视频在线观看| 无限看片的www在线观看| 国产免费男女视频| 亚洲中文日韩欧美视频| 国产精品电影一区二区三区| 久久久久久久久中文| 成人精品一区二区免费| 国产又黄又爽又无遮挡在线| 久久午夜综合久久蜜桃| 级片在线观看| 九色国产91popny在线| 国产成人av激情在线播放| 国产成人啪精品午夜网站| 色综合欧美亚洲国产小说| 成人三级做爰电影| 亚洲欧美激情综合另类| 国产高清视频在线播放一区| 亚洲欧美精品综合一区二区三区| 婷婷精品国产亚洲av| av免费在线观看网站| 变态另类成人亚洲欧美熟女| av福利片在线观看| 亚洲中文字幕一区二区三区有码在线看 | 亚洲熟女毛片儿| 女同久久另类99精品国产91| 欧美三级亚洲精品| 日本成人三级电影网站| 精品一区二区三区视频在线观看免费| 久久香蕉精品热| 久久精品91蜜桃| 国产视频一区二区在线看| 国产精品一区二区精品视频观看| 国产精品一区二区精品视频观看| 黄色成人免费大全| 少妇熟女aⅴ在线视频| 欧美精品亚洲一区二区| 成年版毛片免费区| 757午夜福利合集在线观看| 精品国产亚洲在线| 无遮挡黄片免费观看| 18禁黄网站禁片免费观看直播| 免费av毛片视频| 亚洲,欧美精品.| 日韩欧美一区二区三区在线观看| 美女高潮喷水抽搐中文字幕| 国产三级黄色录像| 国产精品精品国产色婷婷| 久久久久久大精品| a级毛片a级免费在线| 一个人观看的视频www高清免费观看 | 国产午夜精品论理片| 成年版毛片免费区| 国产午夜福利久久久久久| 欧美一区二区精品小视频在线| 国产男靠女视频免费网站| 国产不卡一卡二| 国产主播在线观看一区二区| 色综合亚洲欧美另类图片| 国产av一区二区精品久久| 99精品欧美一区二区三区四区| 淫秽高清视频在线观看| 精品免费久久久久久久清纯| 亚洲黑人精品在线| 好男人在线观看高清免费视频| 两性夫妻黄色片| 精品一区二区三区四区五区乱码| 精品午夜福利视频在线观看一区| 91大片在线观看| 一区二区三区国产精品乱码| 中文资源天堂在线| 老熟妇乱子伦视频在线观看| 不卡一级毛片| 老熟妇仑乱视频hdxx| 少妇人妻一区二区三区视频| 美女午夜性视频免费| 亚洲国产欧美人成| 一级片免费观看大全| 精品熟女少妇八av免费久了| 欧美一级毛片孕妇| 国产精品野战在线观看| 色综合婷婷激情| 婷婷亚洲欧美| 99国产精品一区二区蜜桃av| 禁无遮挡网站| 日本一本二区三区精品| 中文字幕av在线有码专区| 麻豆久久精品国产亚洲av| 午夜免费观看网址| 久久亚洲真实| 欧美3d第一页| 国产熟女xx| www.自偷自拍.com| 久久这里只有精品中国| 亚洲性夜色夜夜综合| 精品熟女少妇八av免费久了| 九色国产91popny在线| 日韩精品中文字幕看吧| 亚洲精品在线美女| 女人高潮潮喷娇喘18禁视频| 精品乱码久久久久久99久播| 最近最新中文字幕大全免费视频| 别揉我奶头~嗯~啊~动态视频| 精品欧美一区二区三区在线| 一夜夜www| 国产高清激情床上av| 两个人免费观看高清视频| 精品久久久久久久久久免费视频| 国产aⅴ精品一区二区三区波| 好看av亚洲va欧美ⅴa在| 欧美三级亚洲精品| 久久人人精品亚洲av| 欧美日本亚洲视频在线播放| www.熟女人妻精品国产| 亚洲第一电影网av| 少妇裸体淫交视频免费看高清 | 国产三级黄色录像| 欧美zozozo另类| 亚洲精华国产精华精| 亚洲国产精品999在线| 国产真人三级小视频在线观看| 日韩三级视频一区二区三区| 少妇裸体淫交视频免费看高清 | 母亲3免费完整高清在线观看| tocl精华| xxxwww97欧美| 最近最新中文字幕大全电影3| 黑人操中国人逼视频| 亚洲精品在线美女| 美女大奶头视频| 女生性感内裤真人,穿戴方法视频| 久久精品国产亚洲av高清一级| 国产成人影院久久av| 午夜老司机福利片| xxx96com| 国产亚洲精品一区二区www| 国产一级毛片七仙女欲春2| av国产免费在线观看| 亚洲无线在线观看| 国产精品99久久99久久久不卡| 国产精品久久久久久亚洲av鲁大| 国产一区二区三区在线臀色熟女| 国产熟女午夜一区二区三区| 亚洲第一欧美日韩一区二区三区| 日韩欧美国产在线观看| 国产99久久九九免费精品| 两性夫妻黄色片| 欧美极品一区二区三区四区| 成人欧美大片| 老熟妇乱子伦视频在线观看| 91字幕亚洲| 久久这里只有精品中国| 淫秽高清视频在线观看| a在线观看视频网站| 久久久久国产一级毛片高清牌| 精品国内亚洲2022精品成人| 欧美日韩精品网址| 国产一级毛片七仙女欲春2| 精华霜和精华液先用哪个| 长腿黑丝高跟| 最近最新免费中文字幕在线| 很黄的视频免费| 久久午夜综合久久蜜桃| 欧美性长视频在线观看| 日本免费一区二区三区高清不卡| 男女做爰动态图高潮gif福利片| av在线天堂中文字幕| 欧美人与性动交α欧美精品济南到| 国产成人影院久久av| 深夜精品福利| 久久国产精品影院| 国产麻豆成人av免费视频| 亚洲国产精品999在线| 亚洲av成人精品一区久久| 非洲黑人性xxxx精品又粗又长| 人成视频在线观看免费观看| 俺也久久电影网| 精品久久蜜臀av无| 麻豆一二三区av精品| 精品国产超薄肉色丝袜足j| 国产又色又爽无遮挡免费看| 国产亚洲欧美在线一区二区| 又大又爽又粗| 狂野欧美激情性xxxx| 黄色毛片三级朝国网站| 亚洲色图av天堂| 国产亚洲精品第一综合不卡| 国产精品国产高清国产av| 亚洲一区二区三区不卡视频| 99久久久亚洲精品蜜臀av| 久久亚洲精品不卡| 国产高清有码在线观看视频 | 女警被强在线播放| 高潮久久久久久久久久久不卡| 色老头精品视频在线观看| av中文乱码字幕在线| 亚洲熟妇熟女久久| 国产av又大| 久久午夜综合久久蜜桃| 日本成人三级电影网站| 亚洲自拍偷在线| 国产精品av久久久久免费| 欧美人与性动交α欧美精品济南到| 日本一本二区三区精品| 在线a可以看的网站| av在线播放免费不卡| 狠狠狠狠99中文字幕| 精品久久蜜臀av无| 一级毛片女人18水好多| 操出白浆在线播放| 国产激情久久老熟女| 亚洲av五月六月丁香网| 色噜噜av男人的天堂激情| 久久久久久久精品吃奶| 欧美另类亚洲清纯唯美| 老熟妇乱子伦视频在线观看| 国产精品一区二区三区四区免费观看 | 婷婷精品国产亚洲av| 亚洲av成人不卡在线观看播放网| 波多野结衣高清作品| 亚洲成av人片免费观看| 国产又黄又爽又无遮挡在线| 亚洲 欧美 日韩 在线 免费| 中文字幕人妻丝袜一区二区| 免费搜索国产男女视频| 一级作爱视频免费观看| 女警被强在线播放| 国产精品一区二区免费欧美| 欧美 亚洲 国产 日韩一| 亚洲性夜色夜夜综合| 最近视频中文字幕2019在线8| 三级毛片av免费| 99国产精品99久久久久| 一区二区三区高清视频在线| 国产高清视频在线观看网站| 真人一进一出gif抽搐免费| 久久热在线av| 色哟哟哟哟哟哟| 亚洲男人天堂网一区| 国产精华一区二区三区| 国产人伦9x9x在线观看| 777久久人妻少妇嫩草av网站| 亚洲成人中文字幕在线播放| av在线天堂中文字幕| 夜夜夜夜夜久久久久| 韩国av一区二区三区四区| 亚洲全国av大片| 国产三级黄色录像| 18禁黄网站禁片午夜丰满| 9191精品国产免费久久| 国产三级中文精品| 久久久精品欧美日韩精品| 国产单亲对白刺激| 搡老熟女国产l中国老女人| 免费看a级黄色片| 嫩草影院精品99| 99热6这里只有精品| 看片在线看免费视频| ponron亚洲| 欧美日韩中文字幕国产精品一区二区三区| 久久久精品国产亚洲av高清涩受| 看黄色毛片网站| 久久久久亚洲av毛片大全| 精品国产乱码久久久久久男人| 国产欧美日韩一区二区精品| 50天的宝宝边吃奶边哭怎么回事| 老汉色∧v一级毛片| 免费高清视频大片| 国产亚洲av嫩草精品影院| 久久人妻av系列| 国产一区二区三区视频了| 十八禁网站免费在线| 在线观看日韩欧美| 18美女黄网站色大片免费观看| 男插女下体视频免费在线播放| 观看免费一级毛片| 国产高清视频在线播放一区| 琪琪午夜伦伦电影理论片6080| 在线看三级毛片| 日本熟妇午夜| av欧美777| 俺也久久电影网| 国产av麻豆久久久久久久| 亚洲一区二区三区色噜噜| 九九热线精品视视频播放| 后天国语完整版免费观看| 九色国产91popny在线| 手机成人av网站| 一区福利在线观看| 日韩高清综合在线| 亚洲欧美日韩高清在线视频| 免费在线观看影片大全网站| 国产午夜精品久久久久久| 很黄的视频免费| 久久久久久久久免费视频了| 国产乱人伦免费视频| 国产精品香港三级国产av潘金莲| 亚洲国产精品成人综合色| 色综合欧美亚洲国产小说| 亚洲人成网站在线播放欧美日韩| 免费在线观看完整版高清| 给我免费播放毛片高清在线观看| 91大片在线观看| 久久久久久人人人人人| 九九热线精品视视频播放| 最新在线观看一区二区三区| 久久精品亚洲精品国产色婷小说| 两个人免费观看高清视频| 欧美成人一区二区免费高清观看 | 精品久久久久久成人av| 老司机在亚洲福利影院| 波多野结衣高清作品| 国产欧美日韩一区二区精品| 在线国产一区二区在线| 国内揄拍国产精品人妻在线| 免费看十八禁软件| 丁香六月欧美| 婷婷精品国产亚洲av在线| 久久人妻福利社区极品人妻图片| 色综合欧美亚洲国产小说| av免费在线观看网站| 国产成年人精品一区二区| 中文字幕精品亚洲无线码一区| 亚洲国产精品合色在线| 少妇被粗大的猛进出69影院| 久久性视频一级片| 精品久久久久久久人妻蜜臀av| 国产亚洲精品第一综合不卡| 成人手机av| 9191精品国产免费久久| 在线永久观看黄色视频| 久久久精品国产亚洲av高清涩受| 免费在线观看视频国产中文字幕亚洲| 国产免费av片在线观看野外av| 麻豆成人午夜福利视频| www日本在线高清视频| 国产欧美日韩一区二区三| 日本一区二区免费在线视频| 日本五十路高清| 亚洲成人中文字幕在线播放| www.www免费av| 成人精品一区二区免费| 亚洲国产精品sss在线观看| 老鸭窝网址在线观看| 国产在线精品亚洲第一网站| 国内少妇人妻偷人精品xxx网站 | 国产午夜精品久久久久久| 久久久久性生活片| 日韩国内少妇激情av| 久久99热这里只有精品18| 桃红色精品国产亚洲av| 天堂av国产一区二区熟女人妻 | 听说在线观看完整版免费高清| 亚洲国产精品久久男人天堂| 亚洲成人免费电影在线观看| 91成年电影在线观看| 国产v大片淫在线免费观看| 国产亚洲av高清不卡| 国产午夜精品久久久久久| 精品久久久久久成人av| ponron亚洲| 人成视频在线观看免费观看| 国产在线精品亚洲第一网站| 少妇人妻一区二区三区视频| 丝袜人妻中文字幕| 欧美高清成人免费视频www| 亚洲美女视频黄频| x7x7x7水蜜桃| av免费在线观看网站| or卡值多少钱| 丰满人妻熟妇乱又伦精品不卡| 999久久久国产精品视频| 人成视频在线观看免费观看| 亚洲av成人精品一区久久| 久久久国产欧美日韩av| www.www免费av| 亚洲午夜理论影院| 国产精品久久久久久精品电影| 欧美色欧美亚洲另类二区| 久久精品91蜜桃| 国产成人精品久久二区二区91| 日本一本二区三区精品| 久久久国产欧美日韩av| tocl精华| 日韩精品中文字幕看吧| 哪里可以看免费的av片| 欧美成人免费av一区二区三区| 亚洲中文字幕一区二区三区有码在线看 | 亚洲人成网站在线播放欧美日韩| 琪琪午夜伦伦电影理论片6080| 日本三级黄在线观看| 午夜免费成人在线视频| 成人手机av| 岛国在线观看网站| 黄色视频不卡| 99热这里只有精品一区 | 国内精品一区二区在线观看| 国产av不卡久久| 亚洲男人的天堂狠狠| 亚洲 国产 在线| 在线观看午夜福利视频| 国产精品亚洲美女久久久| 亚洲av美国av| 精品午夜福利视频在线观看一区| 免费在线观看影片大全网站| 老鸭窝网址在线观看| 中文字幕av在线有码专区| 国产精品久久久人人做人人爽| 男女视频在线观看网站免费 | 欧美黄色片欧美黄色片| 在线观看免费日韩欧美大片| 国产99久久九九免费精品| 国产在线观看jvid| 国产真实乱freesex| 在线观看66精品国产| 午夜亚洲福利在线播放| 成人一区二区视频在线观看| 久久这里只有精品中国| 国产视频内射| 国产99白浆流出| 一级片免费观看大全| 好看av亚洲va欧美ⅴa在| 亚洲精品美女久久久久99蜜臀| 午夜成年电影在线免费观看| 亚洲一卡2卡3卡4卡5卡精品中文| 婷婷丁香在线五月| 午夜福利高清视频| 18美女黄网站色大片免费观看| 精品日产1卡2卡| 精品不卡国产一区二区三区| 国产伦人伦偷精品视频| 天堂av国产一区二区熟女人妻 | 在线观看午夜福利视频| 一本综合久久免费| 日韩三级视频一区二区三区| 制服人妻中文乱码| 男女做爰动态图高潮gif福利片| 日本撒尿小便嘘嘘汇集6| 999精品在线视频| 欧美黑人巨大hd| 欧美乱色亚洲激情| 久久久国产精品麻豆| 精品第一国产精品| 国产精品av视频在线免费观看| 桃色一区二区三区在线观看| 三级国产精品欧美在线观看 | 午夜精品在线福利| 亚洲一区中文字幕在线| 国产精品爽爽va在线观看网站| 精品一区二区三区av网在线观看| 国产又色又爽无遮挡免费看| 精品一区二区三区四区五区乱码| 精品一区二区三区视频在线观看免费| 日韩av在线大香蕉| 好看av亚洲va欧美ⅴa在| 久久精品综合一区二区三区| 久久国产精品人妻蜜桃| 男人舔女人下体高潮全视频| 97超级碰碰碰精品色视频在线观看| 一区二区三区高清视频在线| 男人的好看免费观看在线视频 | 男女之事视频高清在线观看| 看片在线看免费视频| 久久精品影院6| 九色国产91popny在线| 男女做爰动态图高潮gif福利片| 少妇的丰满在线观看| 女人高潮潮喷娇喘18禁视频| 成人av在线播放网站| 窝窝影院91人妻| 精品久久久久久,| 国产日本99.免费观看| 一进一出抽搐gif免费好疼| 1024视频免费在线观看| 亚洲一区中文字幕在线| 天天添夜夜摸| 看片在线看免费视频| 亚洲国产欧洲综合997久久,| 国产高清videossex| 欧美在线黄色| 久久久久久亚洲精品国产蜜桃av| 精品电影一区二区在线| 一本久久中文字幕| 又紧又爽又黄一区二区| 岛国在线免费视频观看| 一本大道久久a久久精品| 91成年电影在线观看| 波多野结衣巨乳人妻| 黄色视频不卡| 中文字幕久久专区| 日韩欧美三级三区| 久久伊人香网站| 国产又色又爽无遮挡免费看| 免费看日本二区| 国产野战对白在线观看| 99热6这里只有精品| 又粗又爽又猛毛片免费看| 亚洲成人久久爱视频| 日韩免费av在线播放| 操出白浆在线播放| 久久婷婷成人综合色麻豆| a在线观看视频网站| 国语自产精品视频在线第100页| 大型av网站在线播放| 亚洲国产精品合色在线| 一夜夜www| 熟妇人妻久久中文字幕3abv| 我要搜黄色片| 国产伦一二天堂av在线观看| av在线天堂中文字幕| 国产午夜精品论理片| 国产精品av久久久久免费| 色综合婷婷激情| 久久久国产精品麻豆| 天堂av国产一区二区熟女人妻 | 男人的好看免费观看在线视频 | 日日干狠狠操夜夜爽| 国产伦在线观看视频一区| 极品教师在线免费播放| 在线国产一区二区在线| av在线天堂中文字幕| 欧美乱码精品一区二区三区| 极品教师在线免费播放| 一本大道久久a久久精品| 成在线人永久免费视频| 91九色精品人成在线观看| 国产一区二区三区在线臀色熟女| 亚洲午夜理论影院| or卡值多少钱| 国产成人精品久久二区二区免费| 午夜福利免费观看在线| 欧美高清成人免费视频www| 久久久久久大精品| 久久精品国产综合久久久| 一个人免费在线观看的高清视频| 9191精品国产免费久久| 中文字幕熟女人妻在线| netflix在线观看网站| 欧美性猛交╳xxx乱大交人| 欧美乱码精品一区二区三区| 少妇裸体淫交视频免费看高清 | 久久人人精品亚洲av| 在线看三级毛片| 午夜福利18| 欧美日韩亚洲国产一区二区在线观看| 男人舔女人下体高潮全视频| 99热这里只有精品一区 | 日韩中文字幕欧美一区二区| 久久久久九九精品影院| 久久久久久免费高清国产稀缺| 国产欧美日韩一区二区精品| 老熟妇仑乱视频hdxx| 日本撒尿小便嘘嘘汇集6| av国产免费在线观看| √禁漫天堂资源中文www| 亚洲,欧美精品.| 免费观看精品视频网站| 变态另类丝袜制服| 一区二区三区国产精品乱码| 国产精品九九99| 在线国产一区二区在线| 黄频高清免费视频| 色老头精品视频在线观看| 国产高清有码在线观看视频 | 国产高清激情床上av| 丰满人妻熟妇乱又伦精品不卡| 欧美黄色片欧美黄色片| 国产探花在线观看一区二区| 久久精品综合一区二区三区| 国产伦在线观看视频一区| 99国产精品一区二区蜜桃av| 一级黄色大片毛片| 欧美乱妇无乱码| www.自偷自拍.com| 首页视频小说图片口味搜索| 男女下面进入的视频免费午夜| 精品久久久久久久久久久久久| 亚洲18禁久久av| 免费一级毛片在线播放高清视频| 欧美性猛交╳xxx乱大交人| 757午夜福利合集在线观看| 一边摸一边抽搐一进一小说| 精品国产亚洲在线| 亚洲人与动物交配视频| 在线视频色国产色| 蜜桃久久精品国产亚洲av| 在线免费观看的www视频| 亚洲av中文字字幕乱码综合| 日韩欧美免费精品| 国产精品免费视频内射| 欧美色视频一区免费| 最好的美女福利视频网| 亚洲av电影不卡..在线观看| 在线永久观看黄色视频| 久久久久久久久免费视频了| 90打野战视频偷拍视频| 激情在线观看视频在线高清| 91国产中文字幕|